Inactive

*Amendment 1: At the request of potential respondents, the submission deadline is extended to 4:00 PM EST, Tuesday, August 30, 2022 (08/30/2022).* The U.S. Department of Health and Human Services (HHS... *Amendment 1: At the request of potential respondents, the submission deadline is extended to 4:00 PM EST, Tuesday, August 30, 2022 (08/30/2022).* The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Division of Cancer Treatment and Diagnosis (DCTD), Developmental Therapeutics Program (DTP) requires assay analysis for the characterization of absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small-molecule drug candidates using standardized in vitro methods. This is a combined synopsis/solicitation for commercial items, prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice, and shall be processed in accordance with FAR Part 13 - Simplified Acquisition Procedures. This announcement constitutes the only solicitation, and a separate written solicitation will not be issued. This solicitation, 75N91022Q00202, is issued as a request for quote (RFQ) and includes all applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2022-07 (08-10-2022), simplified acquisition procedures for commercial items. The North American Industry Classification System code is 541380 – Testing Laboratories with a business size standard of $16.5 million. * See attached Combined Synopsis/Solicitation for more details regarding requirements, terms and conditions, and submittal instructions. * Attachment 1: Combined Synopsis/Solicitation Notice Attachment 2: FAR 52.212-3